PERVASIS THERAPEUTICS

pervasis-therapeutics-logo

Pervasis Therapeutics is a clinical stage company developing a broad portfolio of biologically active therapeutics. Building on its deep understanding of the specialized role that the endothelium plays in regulating natural healing and repair processes associated with disease, Pervasis is advancing groundbreaking new therapies to dramatically improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stents, and peripheral and coronary bypass grafts รขโ‚ฌโ€œ the failure of which result in serious complications and a significant increase in medical costs.

#Financial #Website #More

PERVASIS THERAPEUTICS

Industry:
Biotechnology Medical Therapeutics

Founded:
2003-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.pervasistx.com

Total Employee:
11+

Status:
Closed

Contact:
617-621-3407

Email Addresses:
[email protected]

Total Funding:
42.03 M USD

Technology used in webpage:
Domain Not Resolving NameSilo DNS Internet Initiative Japan


Investors List

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series C - Pervasis Therapeutics

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series C - Pervasis Therapeutics

highland-capital-partners_image

Highland Capital Partners

Highland Capital Partners investment in Series C - Pervasis Therapeutics

polaris-partners_image

Polaris Partners

Polaris Partners investment in Venture Round - Pervasis Therapeutics

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Venture Round - Pervasis Therapeutics

highland-capital-partners_image

Highland Capital Partners

Highland Capital Partners investment in Venture Round - Pervasis Therapeutics

musket-research-associates_image

Musket Research Associates

Musket Research Associates investment in Venture Round - Pervasis Therapeutics

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series B - Pervasis Therapeutics

highland-capital-partners_image

Highland Capital Partners

Highland Capital Partners investment in Series B - Pervasis Therapeutics

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series B - Pervasis Therapeutics

Official Site Inspections

http://www.pervasistx.com

  • Host name: k8s-svc-lander-namesilo-03.us-ord.parklogic.net
  • IP address: 172.237.145.27
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Pervasis Therapeutics" on Search Engine